PT Pyridam Farma Tbk Enters into a Marketing and Promotion Services Agreement with Mundhipharma Healthcare Indonesia
Referring to Financial Service Authority (“OJK”) Regulation No. 31/POJK.04/2015 on Information Disclosure of Material Facts by Issuer of Public Company and Annex to Regulation I-E of Decree of the Board of Directors of PT Bursa Efek No. Kep. 00015/BEI/01-2021 on
Prospectus of Public Offering of Pyridam Farma Bond I 2022
Wednesday, March 2nd 2022 Click to View PDF File
Additional Information of Abridged Prospectus of Public Offering of Pyridam Farma Bond I 2022
Click here to View PDF File
Abridged Prospectus of Public Offering of Pyridam Farma Bond I 2022
Click here to view PDF File
Information Disclosure of Material Transactions for Capital Increase of PT Holi Pharma
Click image to see full document
Completion of the Share Takeover Transaction at PT Holi Pharma by PT Pyridam Farma Tbk
Referring to (i) Financial Service Authority (“FSA”) Regulation No. 31/POJK.04/2015 on Information Disclosure of Material Facts by Issuer of Public Company, (ii) Annex to Regulation I-E of Decree of the Board of Directors of PT Bursa Efek No. KEP-00015/BEI/01-2021 on
OCBC Loans for PT Pyridam Farma Tbk and PT Holi Pharma
Click image to see full PDF
Report of Annual Rating (Obligasi Pyridam Farma I Tahun 2020)
Press Release from KRI Report of Annual Rating (PYFA)
Change of Head of Internal Audit Unit of PT Pyridam Farma Tbk.
Based on the Decree of the Board of Directors of PT Pyridam Farma Tbk. (the “Company”) No. 129/PYFA-DIR/E/XI/2021 dated 19 November 2021 concerning the Dismissal and Appointment of the Head and/or Member of the Internal Audit Unit, and with reference
Information Disclosure
Referring to Financial Service Authority (“OJK”) Regulation No. 31/POJK.04/2015 on Information Disclosure of Material Facts by Issuer of Public Company, we, PT Pyridam Farma Tbk (“Company”) hereby inform that the Company and its affiliate intends to (i) purchase 27,385 shares